Fmr. USTR Official Says Concessions on Drug Protections Would Be Reasonable

The video discusses the differences in drug protection durations between China and the US, highlighting that eight years in China is seen as reasonable. It also explores the potential outcomes of a US-China deal, predicting a brief honeymoon period followed by challenges in implementation. The video anticipates ongoing frictions in areas like technology and investment but hopes for constructive management of these issues.

What potential issues does the speaker foresee in the implementation of the deal?

How does the speaker suggest managing future frictions between the US and China?